A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. (Q47861374)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2017

Language	Label	Description	Also known as
English	A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.	scientific article published in May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

based on heuristic

inferred from title

Joanna K Soczynska

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Sidney H. Kennedy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mary Pat McAndrews

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Roger S McIntyre

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

7

object named as

Elisa Brietzke

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Mohammad Alsuwaidan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Rodrigo B Mansur

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Madeline Li

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Hanna O Woldeyohannes

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Valerie H Taylor

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

1 May 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Bipolar Disorders

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

198-213

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Cytokines in bipolar disorder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

C-reactive protein alterations in bipolar disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Chemokines in bipolar disorder: trait or state?

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Monocyte and microglial activation in patients with mood-stabilized bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A relative resistance of T cells to dexamethasone in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Neutrophilia and lymphopenia in major mood disorders.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Impairment of the blood-CSF barrier in suicide attempters.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Corrigendum to "Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study" [Brain Behav. Immun. (2015)].

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The link between high-sensitivity C-reactive protein and orbitofrontal cortex in euthymic bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The neurocognitive profile of mood disorders - a review of the evidence and methodological issues

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Mood disorders: neurocognitive models

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Inflamed moods: a review of the interactions between inflammation and mood disorders

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Novel therapeutic targets in depression: minocycline as a candidate treatment.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The history of the tetracyclines

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Relation Between Lipophilicity and Pharmacological Behavior of Minocycline, Doxycycline, Tetracycline, and Oxytetracycline in Dogs

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Clinical pharmacokinetics of doxycycline and minocycline

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline: therapeutic potential in psychiatry

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Prospects for minocycline neuroprotection

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline: far beyond an antibiotic

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Tetracyclines: drugs with huge therapeutic potential

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Antidepressant-like actions of minocycline combined with several glutamate antagonists.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Evaluation of safety and efficacy of brain targeted chitosan nanoparticles of minocycline.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline Attenuates Depressive-Like Behaviour Induced by Rat Model of Testicular Torsion: Involvement of Nitric Oxide Pathway.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: Implication for a new schizophrenia animal model.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline restores spatial but not fear memory in olfactory bulbectomized rats.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Microglia and memory: modulation by early-life infection

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate cyclase and amphetamine-induced hyperactivity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Central and peripheral minocycline suppresses motor activity in rats

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of Granulocyte-Macrophage Colony-Stimulating Factor in adult rats.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Reliability of three alternate forms of the trail making tests a and B.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Comparability, reliability, and practice effects on alternate forms of the Digit Symbol Substitution and Symbol Digit Modalities tests.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The immune system and developmental programming of brain and behavior

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Psychoneuroimmunology: conditioning and stress

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Early adversity in chronic depression: clinical correlates and response to pharmacotherapy

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline for Huntington's disease: an open label study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Neuroprotection in Huntington's disease: a 2-year study on minocycline

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline safety and tolerability in Huntington disease

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline in Huntington's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor κB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline modulates cytokine and chemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibiting IκB kinase α/β phosphorylation

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Anti-inflammatory impact of minocycline in a mouse model of tauopathy.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The chemokine system in innate immunity

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

The chemokine superfamily revisited

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Current status of chemokines in the adult CNS.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12496

21 January 2018

Identifiers

10.1111/BDI.12496

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28599348%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47861374&oldid=1707020920"